Form 4: Diane Holder, Evolent Health Director, Reports Stock Purchase
SEC Form 4 Filing
Director Diane Holder reports purchasing 2,735 shares of Evolent Health, Inc. (EVH) at $9.33 per share on March 6, 2025.
Summary
- On March 6, 2025, Diane Holder, a director of Evolent Health, Inc. (EVH), purchased 2,735 shares of Class A Common Stock at a price of $9.33 per share.
- Following this transaction, Holder directly owns 70,584 shares of Evolent Health's Class A Common Stock, which includes restricted stock units granted under previous awards.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard disclosure of an insider stock purchase, which doesn't inherently indicate positive or negative sentiment about the company's future performance.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, makes a transaction in the company's stock. It provides transparency to the market regarding insider activity.
Stakeholder Impact
- The purchase of shares by a director could be perceived positively by shareholders, as it signals confidence in the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of stock purchase transaction |
| 03/10/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.